SENSEX NIFTY
AstraZeneca Pharma Quarterly Results, AstraZeneca Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - AstraZeneca Pharma
AstraZeneca Pharma
BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
, 16:01
1118.55
7.3 (0.66%)
VOLUME 615
LIVE
NSE
, 16:01
1115.40
0.8 (0.07%)
VOLUME 3,547
Download Annual Report PDF Format 2013 | 2012 | 2011

Quarterly Results of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Mar '14 Dec '13 Sep '13 Jun '13 Mar '13
Net Sales/Income from operations 114.15 118.88 115.58 125.14 94.85
Other Operating Income 0.00 0.08 0.08 0.07 0.07
Total Income From Operations 114.15 118.96 115.66 125.20 94.92
EXPENDITURE
Consumption of Raw Materials 14.35 11.84 15.93 21.74 14.55
Purchase of Traded Goods 55.81 28.73 22.96 14.79 30.40
Increase/Decrease in Stocks -25.40 -1.82 0.37 6.82 -13.84
Power & Fuel -- -- -- -- --
Employees Cost 54.71 35.03 36.75 33.97 36.82
Depreciation 2.97 3.03 2.34 1.78 5.48
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 29.58 42.20 41.36 47.23 40.76
P/L Before Other Inc. , Int., Excpt. Items & Tax -17.87 -0.06 -4.06 -1.11 -19.25
Other Income 1.42 1.58 3.34 2.87 0.67
P/L Before Int., Excpt. Items & Tax -16.46 1.52 -0.72 1.77 -18.58
Interest -- -- -- -- --
P/L Before Exceptional Items & Tax -16.46 1.52 -0.72 1.77 -18.58
Exceptional Items 13.89 -- -- -- --
P/L Before Tax -2.57 1.52 -0.72 1.77 -18.58
Tax -- -- 0.51 -- --
P/L After Tax from Ordinary Activities -2.57 1.52 -1.23 1.77 -18.58
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period -2.57 1.52 -1.23 1.77 -18.58
Equity Share Capital 5.00 5.00 5.00 5.00 5.00
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS -1.03 0.61 -0.49 0.71 -7.43
Diluted EPS -1.03 0.61 -0.49 0.71 -7.43
EPS After Extra Ordinary
Basic EPS -1.03 0.61 -0.49 0.71 -7.43
Diluted EPS -1.03 0.61 -0.49 0.71 -7.43
Public Share Holding
No Of Shares (Crores) 0.63 0.63 0.63 0.63 0.25
Share Holding (%) 25.00 25.00 25.00 25.00 10.01
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 1.88 1.88 1.88 1.88 2.25
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 75.00 75.00 75.00 75.00 89.99
Notes
Source : Dion Global Solutions Limited
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.